Cargando…
Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors
Tyrosinase catalyzes two distinct sequential reactions in melanin biosynthesis: The hydroxylation of tyrosine to dihydroxyphenylalanine (DOPA) and the oxidation of DOPA to dopaquinone. Developing functional modulators of tyrosinase is important for therapeutic and cosmetic purposes. Given the abunda...
Autores principales: | Choi, Joonhyeok, Jee, Jun-Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691061/ https://www.ncbi.nlm.nih.gov/pubmed/26633377 http://dx.doi.org/10.3390/ijms161226114 |
Ejemplares similares
-
Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
por: Choi, Joonhyeok, et al.
Publicado: (2017) -
New Inhibitors of Laccase and Tyrosinase by Examination of Cross-Inhibition between Copper-Containing Enzymes
por: Chaudhary, Dinesh, et al.
Publicado: (2021) -
Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase
por: Choi, Joonhyeok, et al.
Publicado: (2022) -
Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor
por: Lee, Wonhwa, et al.
Publicado: (2017) -
Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain
por: Kim, Hyun-Hwi, et al.
Publicado: (2018)